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Cutaneous alternariosis is an opportunistic infection that has been described mainly in patients treated with corticosteroids. We
report a case of dermal alternariosis occurring in a woman treated with corticosteroids after a neurosurgery that was unresponsive
to itraconazole. Treatment with intravenous voriconazole was initiated, followed by oral protocol, with marked improvement of
the lesions.
1. Introduction
Dematiaceous or darkly pigmented fungi are responsible for
a wide variety of infectious diseases. They are often found
in soil and generally distributed worldwide [1]. Alternaria
species are the most important causative agents. They are
opportunistic fungi that mostly infect immunocompromised
patients [2–4]. Most aﬀected individuals are immunode-
pressed due to Cushing disease, kidney transplants, haema-
tologic malignant diseases, and AIDS [5].
2. Case Report
A 76-year-old woman, resident in a rural area, came to our
observation with multiple slowly growing, painless, erythe-
matous infiltrating plaques, with a verrucoid appearance,
occupying the back of hands, forearms, and the distal 2/3
of the arms (Figures 1(a) and 1(b)). She had neurosurgery
15 years before and since then she had been treated with
4mg/day of methylprednisolone orally. The lesions appeared
progressively over two years, they were asymptomatic, and
there was no history of local trauma.
Histopathological examination revealed an intense in-
flammatory process in the dermis, and several septate hyphae
and round or oval spore-like structures that stained positively
with periodic acid Schiﬀ stain (Figures 2(a) and 2(b)).
Cultures of cutaneous biopsies grew Alternaria sp., identified
as Alternaria alternata by DNA analysis. Due to the extension
of the lesions, surgical excision was not feasible. We started
itraconazole (100mg twice daily) and also reduced the corti-
costeroids, but no improvement was observed after 8 months
of treatment. Treatment with intravenous voriconazole at a
dose of 4mg/kg every 12 hours was initiated, followed by
100mg orally after day 10, with marked improvement of
the lesions (Figures 3(a) and 3(b)). However, 4 months after
stopping the voriconazole the patient developed congestive
heart failure. Her condition deteriorated over the time, and
she subsequently died.
3. Discussion
Rare molds are increasingly emerging as a cause of deep and
invasive fungal infections. Cutaneous alternariosis can no
longer be considered rare. Their importance as opportunistic
pathogens is increasing, especially in transplant recipients
[6]. It has also been described with frequency in patients
treated with systemic or local corticosteroids, as in our
patient [7–10]. Cutaneous fragility induced by hypercorti-
cism could be an important cofactor permitting direct inoc-
ulation from the environment [7, 11]. Our patient lived in a
rural area, which could have favored inoculation through a
minor trauma.
Dematiaceous fungi may have unique pathogenic mech-
anisms owing to the presence of melanin in their cell walls.
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Figure 1: Infiltrating plaques, with a verrucoid appearance, occupying the back of hands (a) and forearms (b).
(a)
(b)
Figure 2: Segmented hyphae and spherical spore-like bodies in the
dermis (PAS: (a) 10×; (b) 40×).
It is thought to be a virulence factor by conferring a protec-
tive advantage, scavenging free radicals and hypochlorite that
are produced by phagocytic cells and normally kill most
organisms [1, 10].
Clinically, most presentations are localized skin infec-
tions typically occurring on exposed areas of the body,
especially the arms and legs, resulting from traumatic
inoculation [1, 2, 5, 6, 12].
(a)
(b)
Figure 3: Lesions after 3 weeks of treatment with Voriconazole.
Due to their frequent occurrence as laboratory contam-
inants, Alternaria ssp. must be demonstrated by isolation in
culture plus histologic evidence of its presence in tissues [5].
Therapy is not standardized given the lack of comparative
clinical trials, because these are rare infections. Many anti-
fungals have been used with variable success. Triazoles such
as voriconazole, posaconazole, and itraconazole are the most
active antifungal agents available [1]. Itraconazole is the
preferred drug of choice, because of the lower toxicity and
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easier administration, and because there is greater clinical
experience [12], curiously, in our case itraconazole was
ineﬀective. Surgical excision may be eﬀective, but in our case
was not feasible due to extension of the lesions. Voriconazole
proved an eﬀective alternative, resulting in disappearance of
the lesions. The reason for failure of itraconazole treatment
in our patient is unclear. Subtherapeutic tissue concentration
at the site of infection is possible. Given the lack of
comparative clinical data, decisions over which azole to use
will be largely empiric. Voriconazole and posaconazole are
generally better tolerated and have broader spectrum of
activity.
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